Project

A Randomized multicenter phase III trial comparing enzalutamide vs. a combination of Ra223 and enzalutamide in asymptomatic or mildly symptomatic castration resistant prostate cancer patients metastatic to bone. PEACE III

Ongoing - recruitment closed · 2015 until 2030

Rothermundt Christian, Demmer-Steingruber Ruth, Quinter Janine